Business and Finance Business and Finance
Sun, February 23, 2025
[ Today @ 11:01 AM ] - Insider
I'm a millionaire and my partner makes $60K. I do .. k him to split bills 50-50 because it's not fair.
[ Today @ 11:00 AM ] - Forbes
Men Are Getting Filler Injected Into Their Genitals To Get Larger
[ Today @ 11:00 AM ] - AOL
Forget quiet luxury: America's wealthy 1% are adopting a bolder new approach
[ Today @ 10:41 AM ] - MSN
"Stop wasting cash": Shark Tank investor Kevin O' .. ares the advice he would give to his younger self
[ Today @ 10:41 AM ] - MSN
In auto-centric Michigan, Trump's proposed tariffs polarize a community
[ Today @ 10:41 AM ] - MSN
Abu Dhabi signs groundbreaking agreements with China to strengthen economic, business partnerships
[ Today @ 10:40 AM ] - AOL
Warren Buffett: America's businesses 'usually find a way'
[ Today @ 10:01 AM ] - MSN
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
[ Today @ 09:41 AM ] - MSN
Top global stories this week: HSBC, Alibaba, Airbus among notable names
[ Today @ 09:20 AM ] - Kiplinger
Investing in Art: 10 Things You Should Know
[ Today @ 08:20 AM ] - GeekWire
Qualterra raises $4.5M to turn organic waste into carbon-trapping, crop-boosting biochar
[ Today @ 08:20 AM ] - MSN
Atmus Filtration Technologies Inc. (NYSE:ATMU) Q4 2024 Earnings Call Transcript
[ Today @ 07:20 AM ] - MSN
What happens when a company's 'low performers' speak up
[ Today @ 07:00 AM ] - Newsday
Keeping a bank account: A fearful, challenging process for some on Long Island
[ Today @ 07:00 AM ] - Tuko
Can Kenyans Buy Bread with Crypto? Experts Weigh in on Cryptocurrency Adoption and Everyday Use
[ Today @ 06:40 AM ] - MSN
What Brand Is Behind Costco's Kirkland Signature Frozen Lasagna?
[ Today @ 06:21 AM ] - MSN
Got $5,000? 2 Top Growth Stocks to Buy That Could Double Your Money.
[ Today @ 04:40 AM ] - MSN
2 cities tried basic income for formerly incarcer .. ore food secure but struggled to pay for housing.
[ Today @ 04:20 AM ] - businessday
Top 10 African countries with high sovereign wealth funds
[ Today @ 03:41 AM ] - Tuko
Well-off Hong Kong daunted by record deficits
[ Today @ 03:40 AM ] - Forbes
Why Personal Finance Pressures Can Affect Founder Exit Decisions
[ Today @ 01:20 AM ] - MSN
Hong Kong and Singapore lead Asia's drive to cash in on crypto boom
[ Today @ 12:40 AM ] - MSN
St. Paul Brewing worries city's new development plan will mean the end to their business
[ Today @ 12:21 AM ] - Variety
Warren Buffett Says 'It Won't Be Long' Before Greg Abel Succeeds Him as Berkshire Hathaway CEO
[ Today @ 12:20 AM ] - MSN
German elections: The leaders to watch
Sat, February 22, 2025
[ Yesterday Evening ] - MSN
Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
[ Yesterday Evening ] - MSN
Pfizer Inc. (PFE): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
[ Yesterday Evening ] - AOL
1099-K tax rules: What you need to know if you get paid via Venmo, Cash App or PayPal
[ Yesterday Evening ] - MSN
Trump's IRS layoffs have some Americans asking: 'Why bother' filing taxes this year?
[ Yesterday Evening ] - MSN
Is TriNet Group Inc. (TNET) The Best 52-Week Low Stock To Buy Now According to Short Sellers?

Pfizer Inc. (PFE): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts


Published on 2025-02-22 23:41:08 - MSN
  Print publication without navigation

  • We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other pharmaceutical stocks.

The article from MSN Money discusses the investment potential of Pfizer Inc. (PFE) among other pharmaceutical stocks. It highlights that despite a significant drop in Pfizer's stock price due to declining demand for its COVID-19 related products, the company remains an attractive buy for several reasons. Analysts point out that Pfizer's stock is currently undervalued, trading at a lower price-to-earnings ratio compared to its historical averages and competitors. The company is also diversifying its portfolio beyond COVID-19 treatments, with a robust pipeline of new drugs and potential acquisitions. Moreover, Pfizer offers a high dividend yield, which adds to its appeal for income-focused investors. The article suggests that while the immediate future might be uncertain due to patent expirations and competition, the long-term outlook for Pfizer is positive, supported by its ongoing research and development efforts and strategic business moves.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/general/pfizer-inc-pfe-among-the-cheap-pharmaceutical-stocks-to-buy-according-to-analysts/ar-AA1zAVmR ]
Contributing Sources